Alpha DNA Investment Management’s Cadence Bancorporation CADE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-141
Closed -$2K – 837
2020
Q4
$2K Buy
+141
New +$1.87K ﹤0.01% 503

Other funds holding CADE

Alpha DNA Investment Management's CADE Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Cadence Bancorporation (CADE) in Q1 2021, closing a stake of 141 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in CADE in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 231 funds tracked by Wall St. Rank hold CADE as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Cadence Bancorporation position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 141 Cadence Bancorporation shares in Q1 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in Cadence Bancorporation in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Cadence Bancorporation position peaked at $2K in Q4 2020.
  • 231 funds tracked by Wall St. Rank held Cadence Bancorporation as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.